RESEARCH ALERT-Aerie Pharmaceuticals: Canaccord Genuity starts with buy

Tue Nov 19, 2013 5:11am EST

Nov 19 (Reuters) - Aerie Pharmaceuticals Inc : * Canaccord Genuity starts with buy rating; target price $19 For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/CA

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.